Interactions of ketoprofen and ibuprofen with β-cyclodextrins in solution and in the solid state

Abstract The complexing, solubilizing and amorphizing abilities towards ketoprofen and ibuprofen of native β -cyclodextrin and some randomly substituted amorphous derivatives (methyl, hydroxyethyl, and hydroxypropyl β -cyclodextrin with an average substitution degree per anhydroglucose unit, respectively of 1.8, 1.6 and 0.9) were determined and compared with those already observed for naproxen. Drug-carrier interactions were studied in aqueous solution by means of phase-solubility analysis and 13 C NMR spectroscopy, and in the solid state using differential scanning calorimetry (DSC), X-ray powder diffractometry and infrared spectroscopy. The strength of the inclusion complexes with β -cyclodextrins ( K 1:1,ibu > K 1:1,nap > K 1:1,keto ) was directly related to the hydrophobic character of the guest (log  P values) and depended on its molecular features. The presence in physical mixtures of a high-energy state of crystalline drug molecularly dispersed in the amorphous carrier was assumed from DSC behaviour. Dissolution rates (dispersed amount method) of the active ingredient from equimolar drug-cyclodextrin physical mixtures and amorphous colyophilized products showed that methyl β -cyclodextrin was the most effective carrier also for ketoprofen and ibuprofen.

[1]  T. Higuchi,et al.  Phase solubility techniques , 1965 .

[2]  T. Nagai,et al.  Inclusion compounds of non-steroidal antiinflammatory and other slightly water soluble drugs with alpha- and beta-cyclodextrins in powdered form. , 1975, Chemical & pharmaceutical bulletin.

[3]  K. Terada,et al.  Interaction of tri-O-methyl-β-cyclodextrin with drugs , 1984 .

[4]  C. Hansch,et al.  A NEW SUBSTITUENT CONSTANT, PI, DERIVED FROM PARTITION COEFFICIENTS , 1964 .

[5]  V. Zecchi,et al.  Inclusion complexes between non steroidal antiinflammatory drugs and β-cyclodextrin , 1991 .

[6]  C. Rhodes,et al.  Stereochemical Aspects of the Molecular Pharmaceutics of Ibuprofen , 1993, The Journal of pharmacy and pharmacology.

[7]  Kennath A. Connors Cyclodextrins and their industrial uses: Dominique Duchêne (Editor), Editions de Santé, 19 rue Louis-le-Grand, 75002 Paris, France, 1987, 448 pages, ISBN 2-86411-019-9. , 1988 .

[8]  V. Zecchi,et al.  Dissolution and partition thermodynamic functions of some nonsteroidal anti-inflammatory drugs. , 1986, Journal of pharmaceutical sciences.

[9]  Andrea Gazzaniga,et al.  Thermal behaviour and dissolution properties of naproxen in combinations with chemically modified ß-Cyclodextrins , 1992 .

[10]  K. H. Kim,et al.  Application of differential scanning calorimetry to the study of solid drug dispersions. , 1985, Journal of pharmaceutical sciences.

[11]  K. A. Khan The concept of dissolution efficiency , 1975, The Journal of pharmacy and pharmacology.

[12]  Maurice R. Eftink,et al.  Cyclodextrin-adamantanecarboxylate inclusion complexes: studies of the variation in cavity size , 1985 .

[13]  Fabrizio Melani,et al.  Carbon-13 Nuclear Magnetic Resonance Study of Naproxen Interaction with Cyciodextrins in Solution , 1991 .

[14]  T. Imai,et al.  [Stabilization and reduction of irritant taste of anti-inflammatory drug pirprofen by beta-cyclodextrin complexation]. , 1984, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[15]  O. Corrigan,et al.  Mechanism of drug dissolution rate enhancement from β‐cyclodextrin‐drug systems , 1982 .

[16]  K. Uekama,et al.  Enhancing effects of cyclodextrins on nasal absorption of insulin in rats , 1992 .

[17]  A. Karara,et al.  Characterization, dissolution and bioavailability in rats of ibuprofen-β-cyclodextrin complex system , 1986 .

[18]  G. Giammona,et al.  Comparative study on Inclusion compounds of 4-Biphenylacetic acid with β-Cyclodextrin, Hydroxypropylated-β-Cyclodextrins, and methylated-β-Cyclodextrins , 1994 .

[19]  L. M. Schwartz,et al.  Complexation of 4-biphenylcarboxylate by cyclohexaamylose. A conductometric and carbon-13 nuclear magnetic resonance spectrometric analysis , 1978 .

[20]  J. Guillory,et al.  Heptakis(2,6-di-O-methyl)-beta-cyclodextrin complexation with the antitumor agent chlorambucil. , 1989, Journal of pharmaceutical sciences.

[21]  Y. Sasaki,et al.  Inclusion compounds of cyclodextrin and azo dyes. IV(b): Nuclear magnetic resonance and circular dichroism spectra of γ-cyclodextrin and orange II in the solution state , 1984 .

[22]  V. Zecchi,et al.  Availability of NSAIDH β‐Cyclodextrin Inclusion Complexes , 1989 .

[23]  K. Uekama,et al.  Pharmaceutical evaluation of hydroxyalkyl ethers of β-cyclodextrins , 1988 .

[24]  R. Kümmel,et al.  Dissociation constants, solubilities and dissolution rates of some selected nonsteroidal antiinflammatories , 1983 .

[25]  A. Chiarini,et al.  pH‐Solubility Relationship and Partition Coefficients for some Anti‐Inflammatory Arylaliphatic Acids , 1984 .